Roger D. Tung, Chief Executive Officer at CONCERT PHARMACEUTICALS, INC. (CNCE), sold 6,700 shares at $3.62 ($24K) on 2021-12-13, disclosed to the SEC on 2021-12-15.
Scheduled sale ($24k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CNCE | SELL | 2022-01-07 | $29K | — | Filing → |
| CNCE | SELL | 2021-02-17 | $97K | — | Filing → |
| CNCE | BUY | 2016-05-12 | $414K | — | Filing → |